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Mutations in the ACTN4 gene, encoding the actin crosslinking
protein a-actinin-4, are associated with a familial form of focal
segmental glomerulosclerosis (FSGS). Mice with podocyte-
specific expression of K256E a-actinin-4 develop foot process
effacement and glomerulosclerosis, highlighting the
importance of the cytoskeleton in podocyte structure and
function. K256E a-actinin-4 exhibits increased affinity for
F-actin. However, the downstream effects of this aberrant
binding on podocyte dynamics remain unclear. Wild-type
and K256E a-actinin-4 were expressed in cultured podocytes
via adenoviral infection to determine the effect of the
mutation on a-actinin-4 subcellular localization and on
cytoskeletal-dependent processes such as adhesion,
spreading, migration, and formation of foot process-like
peripheral projections. Wild-type a-actinin-4 was detected
primarily in the Triton-soluble fraction of podocyte lysates
and localized to membrane-associated cortical actin and focal
adhesions, with some expression along stress fibers.
Conversely, K256E a-actinin-4 was detected predominantly in
the Triton-insoluble fraction, was excluded from cortical
actin, and localized almost exclusively along stress fibers.
Both wild-type and K256E a-actinin-4-expressing podocytes
adhered equally to an extracellular matrix (collagen-I).
However, podocytes expressing K256E a-actinin-4 showed a
reduced ability to spread and migrate on collagen-I. Lastly,
K256E a-actinin-4 expression reduced the mean number of
actin-rich peripheral projections. Our data suggest that
aberrant sequestering of K256E a-actinin-4 impairs podocyte
spreading, motility, and reduces the number of peripheral
projections. Such intrinsic cytoskeletal derangements may
underlie initial podocyte damage and foot process
effacement encountered in ACTN4-associated FSGS.
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Focal segmental glomerulosclerosis (FSGS) is a common
glomerular lesion and a significant cause of end-stage renal
disease.1,2 Clinically, FSGS patients present with variable
levels of proteinuria and a progressive loss of renal function.
Pathologically, FSGS is characterized by segmental sclerosis in
a proportion of glomeruli, the filtering units of the kidney.3
Accumulating evidence suggests that defects in podocytes
initiate processes leading to the degeneration of filtration
integrity and the development of sclerotic lesions.4–8
Podocytes are terminally differentiated cells that line the
outer aspects of the glomerular capillaries.9 The highly
ordered podocyte architecture consists of a cell body from
which emerge major processes, which branch into foot
processes that interdigitate with those of neighboring
podocytes to provide the structural platform upon which a
molecular sieve is formed. The foot processes are endowed
with a microfilament-based contractile apparatus composed
of actin, myosin-II, a-actinin, talin, paxillin, and vinculin,10
and are anchored to the glomerular basement membrane via
an a3b1-integrin complex.
11,12 The intricate morphology of
the podocyte, coupled to its exposure to distensile forces
within the glomerular capillary render these cells susceptible
to damage in many nephropathies, including FSGS.
The actin bundling a-actinins are members of the spectrin
superfamily. Four isoforms have been described (a-actinin-1
to -4).13 While a-actinins-2 and -3 are expressed at the Z-line
of striated muscle, a-actinins-1 and -4 are more ubiquitously
expressed. a-Actinin-4 is expressed in podocytes and is
thought to play a key role in the maintenance of this cell’s
architecture.14 The putative function of a-actinin-4, which
exists as a head-to-tail homodimer, is to crosslink actin
filaments through its N-terminal actin-binding domain
comprised of two calponin homology domains. Increasing
evidence suggests that a-actinin-4 may interact with a
number of other proteins such as b1-integrin,
13,15,16 synap-
todpodin,17 vinculin,18 and phosphatidylinositol 3-kinase.19
In addition to an actin-binding domain, a number of other
functional domains are found in the a-actinin-4 sequence –
including two calcium-binding EF hands, a phosphoino-
sitide-binding domain, as well as a focal adhesion kinase (FAK)
tyrosine phosphorylation consensus sequence. Accordingly,
phosphorylation by FAK,20 binding of phosphoinositides,21,22
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and sensitivity to intracellular calcium23 may modulate the
actin-binding properties and localization of a-actinin follow-
ing various environmental stimuli.
Mutations in the ACTN4 gene (K228E, T232I, and S235P)
are associated with an autosomal-dominant form of
FSGS.24,25 We developed a mouse model of ACTN4-
associated FSGS by expressing the murine correlate of the
K228E mutation (K256E) in a podocyte-specific manner
using the mNPHS1 promoter.26 These mice exhibit signifi-
cant proteinuria and develop FSGS-like lesions, confirming
that the disease originates in the podocyte. However, the
mechanism by which mutations in a-actinin-4 dysregulate
podocyte function is not fully understood. Abrogation of
a-actinin-4 expression in mice yields severe glomerular
disease.27 Furthermore, recent studies by Yao et al.28 suggest
that the familial mutations promote a-actinin-4 aggregation
and thereby target the protein for degradation via the
proteasome pathway, resulting in a partial loss-of-function.
In contrast, mutations in a-actinin-4 increase its affinity for
filamentous actin (F-actin), suggesting a gain-of-function
mechanism.24,26 In support of the latter mechanism, the
severity of the FSGS-like phenotype correlates directly
with K256E a-actinin-4 levels in transgenic mice.26 Thus, it
remains unclear whether and how these two viewpoints can
be reconciled.
To address this issue, we assessed the functional con-
sequences of an FSGS-associated mutation (K256E) in
a-actinin-4 at the cellular level. We now report the
intracellular mislocalization of K256E a-actinin-4 in mouse
podocytes, which undermines the processes of cell spreading
and migration, and impairs the formation of actin-rich
peripheral projections. Our data suggest that such defects in
key cytoskeletal-associated processes may compromise the
podocyte’s ability to cope with the demands of the
glomerular environment, maintain foot processes structure,
and thereby initiate the progression towards sclerosis.
RESULTS
Mislocalization of K256E a-actinin-4 in cultured podocytes
Mutations in a-actinin-4 increase its affinity for F-actin
in vitro.24,26 However, the subcellular localization of mutant
a-actinin-4 is not clearly defined. We therefore generated
adenoviral constructs with hemagglutinin (HA)-tagged wild-
type or K256E a-actinin-4 and transduced a conditionally
immortalized mouse podocyte cell line. Podocytes were
infected with a range of virus to determine a concentration
yielding efficient expression (Figure 1a). For all subsequent
experiments, infections were performed with a multiplicity of
infection (MOI) of 25 and incubated for 72 h. There was no
apparent degradation of heterologously expressed K256E
a-actinin-4 during this timeframe as its expression paralleled
that of the wild-type protein (Figure 1a). As shown in
Figure 1b, wild-type a-actinin-4 localized predominantly
with cortical actin. The wild-type protein was also distributed
along stress fibers and at focal adhesions, as identified by
vinculin co-immunofluorescence (Figure 1c). Conversely,
K256E a-actinin-4 was absent from the cell periphery, but
was preferentially associated with stress fibers (Figure 1b) and
focal adhesions (Figure 1c).
Differential association of K256E a-actinin-4 with intracellular
actin pools
We next performed cellular fractionation experiments to deter-
mine the association of wild-type and K256E a-actinin-4
with various intracellular actin pools. Podocytes expressing
wild-type or K256E a-actinin-4 were lysed in Triton X-100-
containing buffer and subject to differential centrifugation.
As shown in Figure 2a and b, only 16.072.5% of the wild-
type a-actinin-4 associated with large cytoskeletal structures
(Triton X-100 insoluble (TI) fraction), whereas 71.475.5%
of the protein remained soluble (Triton X-100 soluble (TS):S
fraction). Conversely, 81.079.6% of the K256E a-actinin-4
was associated with large cytoskeletal structures (TI fraction),
and only 4.973.4% of the mutant protein remained
soluble (TS:S fraction). Expression of both wild-type and
K256E a-actinin-4 was similar, as evidenced by the input.
Furthermore, neither the expression of wild-type nor
K256E a-actinin-4 altered total actin levels. These data
reveal a differential association of wild-type versus K256E
a-actinin-4, with K256E a-actinin-4 sequestered to large
cytoskeletal structures such as actin bundles, whereas wild-
type a-actinin-4 remains predominantly soluble.
Effect of K256E a-actinin-4 expression on cell adhesion,
spreading, and migration
The inappropriate association of K256E a-actinin-4 with the
actin cytoskeleton suggested that it may negatively affect
cytoskeletal dynamics. We therefore determined its effect on
cytoskeletal-dependent processes, such as cell adhesion,
spreading, and migration. Since a-actinin-4 is associated
with focal adhesions, we hypothesized that the mutant
protein may negatively affect the ability of cells to adhere to
an extracellular matrix. Adhesion assays were performed
using podocytes expressing green fluorescent protein (GFP)
alone (control), wild-type a-actinin-4, or K256E a-actinin-4
measuring their ability to bind to collagen-I-coated wells
(Figure 3). The number of adherent cells was quantified
at measuring various time points (3–24 h). Irrespective of
the time allowed for adhesion, there was no difference in
adhesion between wild-type and K256E a-actinin-4-expres-
sing podocytes, suggesting that cell–matrix interactions are
not adversely affected by K256E a-actinin-4.
We next performed a replating assay to assess the ability of
cells expressing either wild-type or K256E a-actinin-4 to
efficiently spread on an extracellular matrix (collagen-I).
Podocytes expressing GFP alone (control), wild-type, or
K256E a-actinin-4 were harvested and replated onto
collagen-I-coated glass coverslips. Adherent cells were fixed
after 3 or 6 h and visualized by immunofluorescence. Within
3 h of replating, a significant number of podocytes had
adhered to the substratum and had begun to spread. For each
condition, we observed no differences in the total number of
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podocytes adhering to the extracellular matrix. However,
at both time points examined, the number of spreading
podocytes was significantly lower in K256E a-actinin-4-
expressing cells (13.070.3% at 3 h; 17.371.0% at 6 h)
compared to control (29.275.8% at 3 h; 37.775.2% at 6 h)
and wild type (34.774.4% at 3 h; 38.475.8% at 6 h) (Figure
4a). Within 6 h of replating, wild-type a-actinin-4 was
localized with cortical actin at the cell periphery (Figure
4b). Conversely, K256E a-actinin-4 remained associated with
F-actin and condensed in the cell body (Figure 4b), consistent
with the observed impairment in cell spreading.
Cell migration relies upon a dynamic cytoskeleton. The
increased affinity of K256E a-actinin-4 for F-actin could
undermine this process. We therefore performed haptotactic
transwell migration assays to determine the effect of K256E
a-actinin-4 on cell migration. Podocytes expressing GFP
alone (control), wild-type, or K256E a-actinin-4 were plated
onto the upper surface of transwell inserts. After 24 h, the
cells remaining in the upper chamber were removed and
the cells that had migrated to the underside of the insert
were quantified. Podocytes expressing wild-type a-actinin-4
migrated at a similar rate (90.879.2%) to control cells
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Figure 1 | Subcellular localization of wild-type and K256E
a-actinin-4 in mouse podocytes. (a) Differentiated podocytes
were incubated with a range of adenoviral doses (multiplicity of
infection 0–50) for wild-type or K256E a-actinin-4 to determine
optimal infection conditions. The expression achieved with both
adenoviruses was similar for each condition. (b) 3 days following
infection with viruses, differentiated podocytes were fixed and
stained with an anti-HA tag antibody to detect a-actinin-4 and
Alexa Fluor 488-phalloidin to detect F-actin. Uninfected cells were
treated in the same manner and serve as control. Wild-type
a-actinin-4 is predominantly found with membrane-associated
cortical actin and process-like projections with limited expression
along stress fibers. Conversely, K256E a-actinin-4 is predominantly
associated with stress fibers and is excluded from the cell periphery.
(c) Wild-type and K256E a-actinin-4 were colocalized with vinculin at
focal adhesion complexes.
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Figure 2 | Distribution of wild-type and K256E a-actinin-4 among
intracellular actin pools. At 3 days post-infection, differentiated
mouse podocytes were lysed in buffer containing 1% Triton X-100
and centrifuged at 15 000 g to pellet the TI fraction containing large
cytoskeletal structures such as actin bundles. The TS fraction was
further centrifuged at 100 000 g to separate G-actin (supernatant, S)
from F-actin (pellet, P). Samples were then analyzed by Western blot
using an anti-HA tag antibody and an anti-actin antibody. (a) A
representative blot and (b) the graphical representation of three
separate experiments illustrate the distribution of a-actinin-4 among
the various actin pools. The majority (71.475.5%) of wild-type
a-actinin-4 remained soluble (S, TS fraction), whereas the majority
(81.079.6%) of K256E a-actinin-4 was associated with actin bundles
(TI fraction). Uninfected cells were treated in the same manner and
serve as control. Input lanes (Inp.) show similar expression levels of
both wild-type and K256E a-actinin-4. *Po0.005 vs wild type (n¼ 3).
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(Figure 5). Conversely, the migration of podocytes expressing
K256E a-actinin-4 was significantly reduced (52.1710.7%;
Po0.01 vs control and wild type). These data suggest that
K256E a-actinin-4 causes defects in cytoskeletal dynamics
and impairs cellular processes such as spreading and
migration.
Quantification of peripheral projections in cultured
podocytes
Podocyte-specific expression of K256E a-actinin-4 leads
to podocyte damage and foot process effacement in vivo.26
The conditionally immortalized podocyte cell line used in the
present studies have been shown to form foot process-like
peripheral projections when cultured under non-permissive
conditions.29 We therefore assessed the effect of K256E
a-actinin-4 on peripheral projections in differentiated
podocytes (Figure 6). Podocytes expressing wild-type a-
actinin-4 displayed a slight increase in the mean number of
projections (3.870.8 projections/cell vs 2.970.6 for control),
whereas podocytes expressing K256E a-actinin-4 exhibited a
decrease in the mean number of projections (1.970.4)
(Figure 6b). Wild-type but not K256E a-actinin-4 was readily
detected in the peripheral projections, along with actin
(Figure 6a). Furthermore, projections emerging from podo-
cytes expressing wild-type a-actinin-4 appeared longer and
thinner than those of control and K256E a-actinin-4-
expressing podocytes. These data provide evidence that
a-actinin-4 plays a key role in the formation and/or
maintenance of peripheral projections in cultured podocytes.
DISCUSSION
We previously developed a mouse model of an inherited form
of FSGS by expressing a mutant variant of a-actinin-4
(K256E) under the control of a podocyte-specific promoter
(mNPHS1).26 In this model, approximately 50% of mice
develop FSGS-like lesions and display podocyte foot process
effacement. However, the direct consequences of mutant
a-actinin-4 on podocyte structure and function remained
unclear. We therefore assessed the effects of K256E a-actinin-4
on the cytoskeletal dynamics of cultured podocytes.
The conditionally immortalized podocyte cell line used in
this study has previously been described in detail.29 These
cells are relatively resistant to conventional transfection
approaches for achieving heterologous expression of pro-
teins. We therefore developed adenoviruses for both
wild-type and K256E a-actinin-4, which yielded significant
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Figure 3 | Effect of a-actinin-4 on podocyte adhesion. Differen-
tiated mouse podocytes expressing either GFP alone (control),
wild-type, or K256E a-actinin-4 were trypsinized and replated onto
collagen-I-coated 96-well U-bottom plates at a density of
5 104 cells/well. Cells were fixed with paraformaldehyde at various
time points, stained with crystal violet, and the absorbance of each
well measured at 595 nm with a spectrophotometric plate reader. At
every time point examined, there was no significant difference in the
ability of wild-type or K256E a-actinin-4-expressing cells to adhere to
an extracellular matrix. Data are from three separate experiments
(n¼ 3) and are expressed as a percent of control for each time point.
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Figure 4 | Effect of a-actinin-4 on podocyte spreading.
Differentiated mouse podocytes expressing GFP alone (control),
wild-type, or K256E a-actinin-4 were trypsinized, held in suspension
for 15 min, and then replated onto collagen-I-coated coverslips and
analyzed by immunofluorescence at 3 and 6 h. (a) Expression of
K256E a-actinin-4 significantly reduced the number of spreading cells
at each time point examined. (b) After 6 h, wild-type a-actinin-4 was
localized to cortical actin, whereas K256E a-actinin-4 remained
condensed within the cell. *Po0.05 vs control and wild-type of
corresponding time point, (n¼ 3).
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expression in a high proportion of cells (90%), rendering the
cell population much more homogeneous than previously
attained. The expression level of both wild-type and mutant
K256E a-actinin-4 were similar (Figure 1a), suggesting
that the mutant protein is not subject to degradation in
these cells.
The most impressive feature upon expression of K256E
a-actinin-4 is its distinct intracellular localization. Although
the putative function of a-actinin-4 is that of an actin
crosslinking protein, we found that the majority of wild-type
a-actinin-4 colocalized with membrane-associated cortical
actin (Figure 1b) or was detected in the TS pool (Figure 2). In
contrast, K256E a-actinin-4 was consistently found along
stress fibers and was retained in the TI fraction (Figure 2).
This sequestration is likely a direct effect of the increased
affinity of K256E a-actinin-4 for F-actin, and is consistent
with a gain-of-function effect of such mutations. In support
of this, an alternative splice variant of a-actinin-4 has
been reported in small-cell lung cancer.30 The splice variant
contains three missense mutations in exon 8, the region
containing FSGS-associated mutations. This mutant isoform
also displays increased affinity for actin, and was found to
colocalize mainly with actin stress fibers, unlike the wild-type
protein, which was concentrated along the periphery of
the cell.
Several reports have identified an association of actinin
isoforms with components of focal adhesion complexes, such
as the b1-integrin subunit and vinculin.
13 Phosphoinositides
may also bind to a-actinin and regulate its interaction with
actin filaments or integrin receptors.21,22 Furthermore,
a-actinin is phosphorylated by FAK in platelets,20 reducing
its cosedimentation with actin filaments. These findings
clearly indicate a role for a-actinin in mediating signals that
could modulate the assembly of focal adhesions or the
cytoskeleton. It is therefore interesting to speculate that
mutations in a-actinin-4, which increase its affinity for actin,
may render the protein insensitive to these factors and
thereby perturb cytoskeletal dynamics.
The mislocalization of mutant a-actinin-4 led us to
investigate its effects on cytoskeletal-dependent processes
such as cell adhesion, spreading, and migration. Although we
did not observe a significant impact of K256E a-actinin-4 on
podocyte adhesion (i.e., adhesion and replating assays), we
found that it significantly affected spreading and migration.
Indeed, podocytes expressing K256E a-actinin-4 remained
rounded and showed severe defects in their ability to spread
on collagen-I. This phenotype is reminiscent of that reported
in FAK-deficient embryonic mesodermal cells,31 which can
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Figure 5 | Effect of a-actinin-4 on podocyte migration.
Differentiated mouse podocytes expressing GFP alone (control),
wild-type, or K256E a-actinin-4 were trypsinized and replated onto
the upper surface of transwell inserts. After 3 h, the cells remaining
in the upper chamber were removed and the cells on the lower
surface were stained with 40,6-diamidino-2-phenylindole and
counted. K256E a-actinin-4 caused a 48% reduction in the number
of migrating cells compared to control and wild type. *Po0.01 vs
control and wild type (n¼ 5).
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Figure 6 | Effect of a-actinin-4 on peripheral projections of
podocytes. At 3 days following infection with viruses for wild-type or
K256E a-actinin-4, differentiated podocytes were fixed and stained
with an anti-HA tag antibody to detect a-actinin-4 and Alexa Fluor
488-phalloidin to detect F-actin. Images in (a) are representative of
cells for each condition and demonstrate actin-rich projections
(arrows) emanating from the cell body. (b) Expression of wild-type
a-actinin-4 caused an increase in the mean number of projections
(3.870.8 projections/cell vs 2.970.6 for control), whereas expression
of K256E a-actinin-4 caused a decrease in the number of projections
(1.970.4). *Po0.05 vs control (n¼ 4).
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adhere but fail to spread effectively on ECM, suggesting that
FAK signaling may be impaired in cells expressing mutant
a-actinin-4. Furthermore, as indicated by the present study,
podocytes expressing K256E a-actinin-4 exhibit severe
motility defects. These findings are in accordance with a
role of actinin-4 in cell motility and cancer invasion,32–34
where cytoplasmic localization of a-actinin-4 is associated
with an infiltrative phenotype in breast cancer cells, whereas
cells with nuclear a-actinin-4 are non-invasive. Our results
show that a-actinin-4 is significantly involved in cell
spreading and migration. The motility deficit seen in
cells expressing K256E a-actinin-4 is likely owing to the
sequestering of the protein to centrally located actin stress
fibers, and away from motility-based structures at the cell’s
periphery.
Expression of wild-type a-actinin-4 increased the mean
number of actin filament-containing peripheral projections
emanating from the cell body, reminiscent of podocyte foot
processes in vivo. In contrast, K256E a-actinin-4 reduced the
mean number of such projections (Figure 6). Although the
arborized phenotype observed in cultured podocytes is not
nearly as extensive as that seen in podocytes in vivo,35 our
data suggest that owing to mislocalization, K256E a-actinin-4
does not provide a suitable framework for the maintenance/
formation of such projections. We previously showed that
podocyte-specific expression of K256E a-actinin-4 leads to
foot process effacement and glomerulosclerosis. Such damage
may be explained by mislocalization of mutant a-actinin-4,
rendering it unresponsive to appropriate signals (e.g., actin
remodeling) or unable to provide structural support at the
cell membrane, and thereby contribute to foot process
effacement.
A recent study by Yao et al.28 attributes podocyte defects
encountered in ACTN4-associated FSGS to a loss-of-function
as mutations render a-actinin-4 more susceptible to forming
unstable aggregates, which are rapidly degraded via the
proteasome pathway. Conversely, in transgenic mice expres-
sing an FSGS-associated mutant a-actinin-4, podocyte
damage and sclerosis correlate directly with mutant transgene
expression, consistent with a gain-of-function mechanism.26
We did not observe any degradation of exogenous K256E
a-actinin-4 in cultured podocytes (Figure 1a) within the
experimental timeframe. In light of these findings, we favor a
synthesis of the two models to explain the dysregulated
phenotype of podocytes expressing FSGS-associated mutant
a-actinin-4. Gain-of-affinity mutations in a-actinin-4,
coupled with some degradation of the mutant protein, could
each contribute to a loss-of-function by effectively eliminat-
ing this protein from select intracellular locales (e.g.,
motility-based actin structures and process-like peripheral
projections), thereby disturbing cytoskeletal-dependent pro-
cesses such as cell spreading, migration, and importantly,
process maintenance/formation. In support of this hypo-
thesis, dysregulation of the actin cytoskeleton and a-actinin-4
expression/localization has been reported in various glomer-
ular disease models characterized by podocyte foot process
effacement,6,36–38 and is therefore likely to be a key event in
the progression of podocyte injury.
In summary, we have further defined the functional
consequences of an FSGS-associated form of the actin-
crosslinking protein – K256E a-actinin-4. Whereas wild-type
a-actinin-4 is predominantly localized to membrane-asso-
ciated cortical actin in conditionally immortalized podocytes,
K256E a-actinin-4 remains tightly associated with stress
fibers. Mislocalization of K256E a-actinin-4 causes severe
defects in motility, including cell spreading and migration.
Furthermore, K256E a-actinin-4 caused a decrease in the
number of foot process-like peripheral projections. Our data
therefore suggest that dysregulation of the podocyte cyto-
skeleton may play a key role in the progression of sclerotic
lesions resulting from various podocyte injuries.
MATERIALS AND METHODS
Adenoviral constructs
Adenoviral constructs containing wild-type or K256E murine HA-
ACTN4 sequences were generated by subcloning from the previously
described pcDNA3-HA-ACTN4 vectors.26 In these viruses, the HA-
ACTN4 expression cassette replaced the E1-region and transcription
is directed rightward, relative to the conventional human adenovirus
serotype 5 map. The E1-deleted, first-generation Adenovirus vectors
used in these studies were constructed using a combination of
conventional cloning techniques and RecA-mediated recombina-
tion,39,40 and were grown and titered on 293 cells, as described
previously.41
Cell culture
Conditionally immortalized mouse podocytes were cultured on
collagen-I-coated dishes in RPMI-1640 supplemented with 10%
fetal bovine serum, 100 U/ml of penicillin, 100 mg/ml of strepto-
mycin, 100 mg/ml of Normocin (InvivoGen, San Diego, CA, USA),
and 10 U/ml g-interferon (Sigma, Oakville, Ontario, Canada) at
331C (permissive conditions). For differentiation, cells were cultured
at 381C without g-interferon (non-permissive conditions) for at
least 10 days. Cells used for experiments were between passages 5
and 15 only. Differentiated podocytes were infected with a range of
viral loads (multiplicity of infection between 0 and 50 plaque-
forming units/cell) to determine optimal infection conditions.
Lysates (10mg total protein) were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and transferred to
nitrocellulose membranes. Immunoblots were incubated with a
monoclonal anti-HA antibody (HA-7, Sigma, 1:1000), followed by a
horseradish peroxidase-conjugated secondary antibody and devel-
oped using Supersignal West Pico Chemiluminescence (Pierce,
Rockford, IL, USA). Immunoblots were stripped and reprobed with
an anti-actin antibody (Sigma, 1:1000). For all subsequent
experiments, differentiated podocytes were infected at a multiplicity
of infection of 25 plaque-forming units/cell and incubated for 72 h
to achieve sufficient protein expression.
Fluorescence microscopy
At 3 days post-infection, podocytes grown on collagen-coated
coverslips were processed for immunofluorescence. Cells were fixed
with 4% paraformaldehyde, washed with phosphate-buffered saline
(PBS), permeabilized with 0.2% Triton X-100, blocked with 2%
bovine serum albumin, and incubated with an anti-HA tag antibody
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(Inter Medico, Markham, Ontario, Canada, 1:200 or HA-7, Sigma,
1:1000). Cells were then double-labeled with appropriate Alexa
Fluor-conjugated secondary antibodies and Alexa Fluor-conjugated
phalloidin (both form Molecular Probes, Eugene, OR, USA, 1:1000).
To visualize focal adhesions, cells were labeled with an anti-vinculin
antibody (Vin11.5, Sigma, 1:100) followed by appropriate Alexa
Fluor-conjugated secondary antibodies and phalloidin. Images were
captured using a Zeiss AxioCam and a Zeiss Axioskop 2 fluorescence
microscope (Zeiss Axioskop 2 MOT, Zeiss, Germany).
Fractionation of intracellular actin pools
Infected differentiated mouse podocytes were scraped into ice-cold
lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM ethyleneglycol
tetraacetate, 1 mM ethylenediaminetetraacetic acid, 1% Triton X-100,
0.5% Nonidet P-40) supplemented with protease inhibitor cocktail
(Sigma, 1:100) and phenylmethylsulfonyl fluoride, and incubated at
room temperature for 15 min. Cell lysates were then centrifuged at
15 000 g to isolate the TI fraction. The TS fraction was removed and
further centrifuged at 100 000 g to separate G-actin (supernatant, S)
and F-actin (pellet, P). All pellets were resuspended in the original
sample volume. A small aliquot of the total lysate was reserved for
protein determination using a Bicinchoninic Acid Protein Assay Kit
(Pierce). Samples of equal volume (10 mg total protein in lysate)
were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and transferred to nitrocellulose membranes. The
membranes were probed with a polyclonal anti-HA tag antibody
(Clontech, Palo Alto, CA, USA, 1:1000) followed by a horseradish
peroxidase-conjugated secondary antibody and developed using
Supersignal West Pico Chemiluminescent Substrate (Pierce). The
immunoblots were subsequently stripped and reprobed with an
anti-actin antibody (Sigma, 1:1000). The membranes were exposed
to film, images were scanned with a Hewlett Packard ScanJet 6100C,
and densitometry of the bands measured using Kodak 1D 3.5
software.
Cell adhesion assays
Differentiated mouse podocytes, having been infected with adeno-
virus 72 h earlier, were harvested by trypsin/ethylenediaminetetraa-
cetic acid treatment, centrifuged, and resuspended in RPMI
containing 10% fetal bovine serum and counted with a hemacyto-
meter. Cells were seeded onto collagen-I-coated U-bottom 96-well
plates (5 104 cells/well) and incubated at 381C. At various times
after seeding (3, 6, 12, and 24 h), the wells were washed with PBS
and the cells fixed with 4% paraformaldehyde for 30 min at room
temperature. Adherent cells were then stained with 1% crystal violet
for 30 min, washed five times with PBS, and solubilized in 20%
acetic acid. The absorbance (595 nm) of each well was then
measured using a FLUOstar Galaxy plate reader. Data are from
three separate experiments and are expressed as a function of
control cells.
Cell replating assays
Differentiated mouse podocytes, having been infected with adeno-
virus 72 h earlier, were harvested by trypsin/ethylenediaminetetra-
acetic acid treatment. Following trypsin inactivation with soybean
trypsin inhibitor (Sigma, 0.5 mg/ml), the cells were collected by
centrifugation, washed once, and held in suspension for 15 min at
381C in RPMI containing 10% fetal bovine serum. Suspended cells
were counted with a hemacytometer, seeded onto collagen-I-coated
glass coverslips (5 104 cells/well), and incubated at 381C. At 3 and
6 h following replating, the wells were washed with PBS, and
adherent cells fixed with 4% paraformaldehyde and processed for
immunofluorescence as above. The number of spreading cells was
counted (three separate experiments) and is expressed as a
percentage of infected cells.
Cell migration assays
Differentiated mouse podocytes, having been infected with adeno-
virus 72 h earlier, were harvested by trypsin/ethylenediaminetetra-
acetic acid treatment. Following trypsin inactivation with soybean
trypsin inhibitor (0.5 mg/ml), cells were collected by centrifugation
and resuspended in RPMI þ 10% fetal bovine serum. Suspended
cells were counted by hemacytometer and seeded onto the upper
chamber of transwell inserts (5 104 cells/insert) pre-coated on the
lower surface with collagen-I. After a 24 h incubation at 381C, cells
on the upper surface were removed with a cotton-tip applicator and
the migrating cells on the lower surface of the insert were washed
with PBS, fixed with paraformaldehyde, and stained with 40,6-
diamidino-2-phenylindole. Membranes were removed from the
inserts, placed on slides, and migrating cells were quantified by
counting 40,6-diamidino-2-phenylindole-stained nuclei. Data are
from five experiments expressed as the percentage of control.
Quantification of peripheral projections in cultured
podocytes
Differentiated podocytes grown on collagen-I-coated coverslips were
infected with adenoviruses for wild-type or K2565E a-actinin-4 and
processed for immunofluorescence as described above (Fluorescence
microsocopy). Peripheral projections emanating from the cell body
of HA-positive cells were quantified in a minimum of 50 cells from
four experiments. Data are the mean number of projections per cell.
Uninfected cells served as controls.
Statistics
Values reported are the means7s.e.m. from at least three
experiments. Statistical comparisons were made using unpaired
t-test or one-way analysis of variance followed by the Newman–Keuls
multiple comparison test.
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